Urmăriți
Fengying Tang
Fengying Tang
Adresă de e-mail confirmată pe uw.edu
Titlu
Citat de
Citat de
Anul
Glycosaminoglycan and Proteoglycan‐Based Biomaterials: Current Trends and Future Perspectives
J Rnjak‐Kovacina, F Tang, JM Whitelock, MS Lord
Advanced healthcare materials 7 (6), 1701042, 2018
672018
The multifaceted roles of perlecan in fibrosis
MS Lord, F Tang, J Rnjak-Kovacina, JGW Smith, J Melrose, JM Whitelock
Matrix Biology 68, 150-166, 2018
522018
Plasma ion implantation of silk biomaterials enabling direct covalent immobilization of bioactive agents for enhanced cellular responses
A Kondyurin, K Lau, F Tang, B Akhavan, W Chrzanowski, MS Lord, ...
ACS applied materials & interfaces 10 (21), 17605-17616, 2018
472018
Silk biomaterials functionalized with recombinant domain V of human perlecan modulate endothelial cell and platelet interactions for vascular applications
J Rnjak-Kovacina, F Tang, JM Whitelock, MS Lord
Colloids and Surfaces B: Biointerfaces 148, 130-138, 2016
382016
Microchannels are an architectural cue that promotes integration and vascularization of silk biomaterials in vivo
F Tang, XD Manz, A Bongers, RA Odell, H Joukhdar, JM Whitelock, ...
ACS Biomaterials Science & Engineering 6 (3), 1476-1486, 2020
302020
A Biomimetic Approach toward Enhancing Angiogenesis: Recombinantly Expressed Domain V of Human Perlecan Is a Bioactive Molecule That Promotes Angiogenesis and Vascularization …
X Lin, F Tang, S Jiang, H Khamis, A Bongers, JM Whitelock, MS Lord, ...
Advanced Science, 2000900, 2020
302020
Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion
F Tang, MS Lord, WB Stallcup, JM Whitelock
The Journal of Biochemistry 163 (5), 399-412, 2018
302018
Bioengineered human heparin with anticoagulant activity
MS Lord, B Cheng, F Tang, JG Lyons, J Rnjak-Kovacina, JM Whitelock
Metabolic Engineering 38, 105-114, 2016
282016
Recombinant domain V of human perlecan is a bioactive vascular proteoglycan
J Rnjak‐Kovacina, F Tang, X Lin, JM Whitelock, MS Lord
Biotechnology journal 12 (12), 1700196, 2017
252017
Biomimetic silk biomaterials: perlecan-functionalized silk fibroin for use in blood-contacting devices
K Lau, A Waterhouse, B Akhavan, L Gao, HN Kim, F Tang, JM Whitelock, ...
Acta Biomaterialia 132, 162-175, 2021
242021
ROS-mediated anti-angiogenic activity of cerium oxide nanoparticles in melanoma cells
JM Yong, L Fu, F Tang, P Yu, RP Kuchel, JM Whitelock, MS Lord
ACS Biomaterials Science & Engineering 8 (2), 512-525, 2022
192022
Silk fibroin photo-lyogels containing microchannels as a biomaterial platform for in situ tissue engineering
M Baptista, H Joukhdar, CR Alcala-Orozco, K Lau, S Jiang, X Cui, S He, ...
Biomaterials Science 8 (24), 7093-7105, 2020
142020
Defining the versican interactome in lung health and disease
F Tang, JE Brune, MY Chang, SR Reeves, WA Altemeier, CW Frevert
American Journal of Physiology-Cell Physiology 323 (2), C249-C276, 2022
92022
Engineered short forms of perlecan enhance angiogenesis by potentiating growth factor signalling
HN Kim, Z Elgundi, X Lin, L Fu, F Tang, ESX Moh, MS Jung, ...
Journal of Controlled Release 362, 184-196, 2023
22023
Inter-alpha-trypsin inhibitor (IαI) and hyaluronan modifications enhance the innate immune response to influenza virus in the lung
F Tang, SR Reeves, JE Brune, MY Chang, CK Chan, P Waldron, ...
Matrix Biology 126, 25-42, 2024
12024
Sulfation Signatures of Chondroitin Sulfate Proteoglycans Unveiled Through Mass Spectrometry and Nanopore Sequencing
X Zhou, F Tang, CW Frevert, J Nivala, K Alonge
GLYCOBIOLOGY 33 (11), 1067-1067, 2023
2023
The multifaceted roles of perlecan in fibrosis
J Melrose, M Lord, J Rnjak-Kovacina, J Smith, F Tang, JM Whitelock
Elsevier, 2018
2018
Plasma Immersion Ion Implantation Treatment of Silk Biomaterials Enhances Biological Function
F Tang, K Lau, A Kondyurin, MS Lord, J Whitelock, M Bilek, ...
TISSUE ENGINEERING PART A 22, S129-S129, 2016
2016
Domain V of Perlecan Covalently Immobilized on Silk Biomaterials Modulates Endothelial Cell and Platelet Interactions for Vascular Applications
J Rnjak-Kovacina, F Tang, JM Whitelock, MS Lord
TISSUE ENGINEERING PART A 22, S20-S21, 2016
2016
Bioengineering of Human Heparin: A Next Generation Anti‐coagulant
J Whitelock, B Cheng, F Tang, G Lyons, M Lord
The FASEB Journal 30, 1070.5-1070.5, 2016
2016
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20